Investigating hidden heart rhythm issues in African Americans
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study
This study is looking for hidden heart rhythm problems in African Americans to help prevent serious health issues like strokes and memory loss, by using a simple heart monitor that tracks your heartbeat for two weeks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10459370 on NIH RePORTER |
What this research studies
This research focuses on identifying subclinical atrial fibrillation (AF) and supraventricular ectopy (SVE) in African Americans, who may be at risk for serious health issues like stroke and cognitive decline. Using a non-invasive electrocardiographic monitoring device, the study will continuously track heart rhythms in 2,000 participants over 14 days to uncover hidden arrhythmias that often go undetected. By understanding the prevalence and risk factors associated with these conditions, the research aims to improve cardiovascular disease prevention strategies tailored for this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals participating in the Jackson Heart Study who may be at risk for subclinical atrial fibrillation or supraventricular ectopy.
Not a fit: Patients who do not identify as African American or those who are not part of the Jackson Heart Study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better detection and prevention of serious heart-related issues in African Americans, ultimately reducing the risk of stroke and cognitive impairment.
How similar studies have performed: Other research has shown success in using continuous ECG monitoring to detect arrhythmias, indicating that this approach is promising and not entirely novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Floyd, James S — University of Washington
- Study coordinator: Floyd, James S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.